11-63590230-G-A
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_001128203.2(PLAAT3):c.257C>T(p.Pro86Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000052 in 1,614,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001128203.2 missense
Scores
Clinical Significance
Conservation
Publications
- lipodystrophy, familial partial, type 9Inheritance: AR Classification: LIMITED Submitted by: G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLAAT3 | NM_001128203.2 | c.257C>T | p.Pro86Leu | missense_variant | Exon 4 of 5 | ENST00000415826.3 | NP_001121675.1 | |
PLAAT3 | NM_007069.3 | c.257C>T | p.Pro86Leu | missense_variant | Exon 3 of 4 | NP_009000.2 | ||
PLAAT3 | XM_011544741.2 | c.302C>T | p.Pro101Leu | missense_variant | Exon 3 of 4 | XP_011543043.1 | ||
LOC105369335 | XR_950179.3 | n.*140G>A | downstream_gene_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152228Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251386 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1461880Hom.: 0 Cov.: 33 AF XY: 0.0000633 AC XY: 46AN XY: 727244 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74370 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.257C>T (p.P86L) alteration is located in exon 3 (coding exon 3) of the PLA2G16 gene. This alteration results from a C to T substitution at nucleotide position 257, causing the proline (P) at amino acid position 86 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at